Angiogenic evaluation of ginsenoside Rg1 from Panax ginseng in fluorescent transgenic mice

Vascular Pharmacology

Volumn 49, Issue 1, 2008, Pages 37-43

  Lin, Kurt Ming Chao ^a   Hsu, Ching Han ^b   Rajasekaran, Subbiah ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Angiogenesis; bFGF; Confocal laser scanning microscopy; Fluorescent transgenic mice; Ginsenoside Rg1

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GINSENOSIDE RG 1; GREEN FLUORESCENT PROTEIN; MATRIGEL; TRIMETREXATE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CULTURE MEDIUM; DENSITY; FLUORESCENCE; GINSENG; IMAGE ANALYSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE ENGINEERING; TISSUE REGENERATION; TRANSGENIC MOUSE;

ANIMALS; CELL PROLIFERATION; COLLAGEN; DRUG COMBINATIONS; GINSENOSIDES; GREEN FLUORESCENT PROTEINS; HEMOGLOBINS; HISTOCYTOCHEMISTRY; IMAGE PROCESSING, COMPUTER-ASSISTED; LAMININ; LUMINESCENT AGENTS; MALE; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PHYSIOLOGIC; PANAX; PROTEOGLYCANS;

EID: 46849109553     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2008.05.002     Document Type: Article

References (37)

1. Akhtar N., Dickerson E.B., and Auerbach R. The sponge/matrigel angiogenesis assay. Angiogenesis 5 (2002) 75-80
2. Attele A.S., Wu J.A., and Yuan C.S. Ginseng pharmacology multiple constituents and multiple actions. Biochemical Pharmacology 58 (1999) 1685-1693
3. Auerbach R., Akhtar N., Lewis R.L., and Shinners B.L. Angiogenesis assays: problems and pitfalls. Cancer and Metastasis Reviews 19 (2000) 167-172
4. Bader A., Schiling T., and Teebken O.E. Tissue engineering of heart valves-human endothelial cell seeding of detergent acellularized porcine valves. European Journal of Cardio-thoracic Surgery 14 (1998) 279-284
5. Beat A.I., and Michel A.L. Angiogenesis and inflammation face off. Nature Medicine 12 (2006) 171-172
6. Caccia P., Nitti G., Cletini O., Pucci P., Ruoppolo M., Bertolero R., Valsasina B., Roletto E., Cristiani C., Cauet G., Sarmientos P., Malorni A., and Marino G. Stabilization of recombinant human basic fibroblast growth factor by chemical modifications of cycteine residues. European Journal of Biochemistry 204 (1992) 649-655
7. 1 derived from Panaxnoto ginseng. Journal of Clinical Endocrinology and Metabolism 87 (2002) 3691-3695
8. 1 and Re, isolated from Panax ginseng: in vitro and in vivo studies. International Journal of Pharmaceutics 328 (2007) 168-176
9. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocrine Reviews 25 (2004) 581-611
10. Folkman J., and Yuen S. Angiogenesis. Journal of Biological Chemistry 267 (1992) 10931-10934
11. Fransson J., Hallen D., and Florin-Robertsson E. Solvent effects on the solubility and physical stability of human insuline-like growth factor1. Pharmaceutical Research 14 (1997) 606-612
12. Grant D.S., Kinsella J.L., and Fridman R. Interaction of endothelial cells with a laminin a chain peptide (SIKVAV) in vitro and induction of angiogenic behaviour in vivo. Journal of Cellular Physiology 153 (1992) 614-625
13. Griffith L.G., and Naughton G. Tissue engineering: current challenges and expanding opportunities. Science 295 (2002) 1009-1014
14. Huang Y.C., Chen C.T., Chen S.C., Lai P.H., Liang H.C., Chang Y., Yu L.C., and Sung H.W. A natural compound (ginsenoside Re) isolated from Panax ginseng as a novel angiogenic agent for tissue regeneration. Pharmaceutical Research 22 (2005) 636-646
15. 6 March. Image J (Version 1.35). From the National Institutes of Health (2006). http://rsb.info.nih.gov/ij/
16. Jain R.K., Schlenger K., Hoeckel M., and Yuan F. Quantitative angiogenesis assays: progress and problems. Nature Medicine 3 (1997) 1203-1208
17. Katoh R., Hemmi A., Komiyama A., and Kawaoi A. Confocal laser scanning microscopic observation of angioarchitectures in human thyroid neoplasms. Human Pathology 30 (1999) 1226-1231
18. Kawaguchi N., Toriyama K., Nicodemou-Lena E., Inou K., Torii S., and Kitagawa Y. De novo adipogenesis in mice at the site of injection of basement membrane and basic fibroblast growth factor. Proceedings of the National Academy of Sciences of the United States of America 95 (1998) 1062-1066
19. Kelm J.M., Ehler E., Nielsen L.K., Schlatter S., Perriard J.C., and Fussenegger M. Design of artificial myocardial nicrotissues. Tissue Engineering 10 (2004) 201-214
20. Ley C.D., Olsen M.W.B., Lund E.L., and Kristjansen P.E.G. Angiogenic synergy of bFGF and VEGF is antagonized by angiopoietin-2 in a modified in vivo matrigel assay. Microvascular Research 68 (2004) 161-168
21. 1 in an acellular biological tissue for tissue regeneration. Tissue Engineering 11 (2005) 835-846
22. Liu Chang X., and Xiao Pei G. Recent advances on ginseng research in China. Journal of Ethnopharmacology 36 (1992) 27-38
23. Morales D.E., McGowan K.A., Grant D.S., Maheshwari S., Bhartiya D., Cid M.C., Kleinman H.K., and Schnaper H.W. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 91 (1995) 755-763
24. Murphy W.L., Simmons C.A., and Kaigher D. Bone regeneration via a mineral substrate and induced angiogenesis. Journal of Dental Research 83 (2004) 204-210
25. Passaniti A., Taylor R.M., Pili R., Guo Y., Long P.V., Haney J.A., Pauly R.R., Grant D.S., and Martin G.R. A simple, quantitative method for assessing angiogenesis and antiangiogenetic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Laboratory Investigation 67 (1992) 519-528
26. 1 effects on mesencephalic dopaminergic cells stressed with glutamate. Brain Research 1021 (2004) 41-53
27. Rafael C., Richard G., and Woods E. Digital Image Processing (2002), Prentice Hall, New Jersey
28. Rifkin D.B., and Moscatelli D. Recent developments in the cell biology of basic fibroblast growth factor. Journal of Cell Biology 109 (1989) 1-6
29. Sakamoto H., Mashima T., Kizaki A., Dan S., Hashimoto Y., Naito M., and Tsuruo T. Glyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosis. Blood 95 (2000) 3214-3218
30. Shah D., Johnston T.P., and Mitra A.K. Thermodynamic parameters associated with guanidine HCl- and temperature-induced unfolding of bFGF. International Journal of Pharmaceutics 169 (1998) 1-14
31. Tabata Y. Tissue regeneration based on growth factor release. Tissue Engineering 9 (2003) S5-S15
32. Tabata Y., Miyao M., Yamamoto M., and Ikada Y. Vascularization into a porous sponge by sustained release of basic fibroblast growth factor. Journal of Biomaterials Science. Polymer Edition 10 (1999) 957-968
33. Tongay S., Dag S., Durgun E., Senger R.T., and Ciraci S. Atomic and electronic structure of carbon strings. Journal of Physics. Condensed Matter 17 (2005) 3823-3836
34. Vemuri S., Beylin I., Sluzky V., Stratton P., Eberlein G., and Wang Y.J. The stability of bFGF against thermal denaturation. Journal of Pharmacy and Pharmacology 46 (1994) 481-486
35. Walton R.L., Beahm E.K., and Wu L. De novo adipose formation in a vascularized engineered construct. Microsurgery 24 (2004) 378-384
36. 1 in vivo and in vitro. Angiogenesis 8 (2005) 205-216
37. Zisch A.H., Lutolf M.P., and Ehrbar M. Cell-demanded release of VEGF from synthetic, biointeractive cell in growth matrices for vascularized tissue growth. Journal of the Federation of American Societies for Experimental Biology 17 (2003) 2260-2272